SCIENTIFIC JOURNAL of the Hungarian Society of Cardiology

Ventricular tachycardia ablation: indications, patient management, state of the art

█ Review

DOI: 10.26430/CHUNGARICA.2023.53.3.205

Komlósi Ferenc, Tóth Patrik, Vámosi Péter, Szakál Imre, Szegedi Nándor, Zima Endre, Salló Zoltán, Perge Péter, Osztheimer István, Nagy Klaudia Vivien*, Gellér László*
Semmelweis Egyetem, Városmajori Szív- és Érgyógyászati Klinika, Budapest
*megosztott utolsó szerzők
Levelezési cím:
Dr. Nagy Klaudia Vivien, 1122 Budapest, Városmajor utca 68.

Ventricular tachycardia (VT) is one of the most common causes of sudden cardiac death, its most prevalent etiology being ischemic heart disease. Cornerstones of therapy include implantable cardioverter defibrillator (ICD), antiarrhythmic drugs and catheter ablation. While ICDs only prevent sudden cardiac death, antiarrhythmics are often ineffective and have serious side effects. Therefore, the rapid evolution of catheter ablation established its important role in the therapy of VT. In our paper we present the current indications of catheter ablation in VT, discussing the supporting body of evidence. We summarize the most common cases where referral to specialized centers is recommended. Additionally, we present some of the European and Hungarian statistics regarding VT management. Furthermore, we summarize the newest scientific discoveries in the field, focusing on two questions of intensive debate: whether catheter ablation can improve survival in VT and the incertainties around the optimal timing of catheter ablation.


click here to read the full article

click here to read the pdf

Watch the video summary